
|Podcasts|July 6, 2020
Speaking of Urology podcast: Dr. Angela Smith discusses Jelmyto for low-grade UTUC
Author(s)Urology Times staff
In this episode, Angela B. Smith, MD, MS, of UNC Lineberger Comprehensive Cancer Center, discusses the recent FDA approval of Jelmyto, which is the first therapy for the treatment of low-grade upper tract urothelial cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
2
Amy E. Krambeck, MD, on choosing between CVAC and FANS for suction-based ureteroscopy
3
Urocross shows sustained benefit through 24 months post-removal
4
Study suggests tamsulosin deprescribing may be appropriate for select men with BPH
5













